Literature DB >> 21221559

Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt-Jakob disease: correlation with clinical course.

Jae Hyoung Kim1, Byung Se Choi, Cheolkyu Jung, YoungHee Chang, SangYun Kim.   

Abstract

INTRODUCTION: Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal disease with variable clinical courses. The presence or absence of basal ganglia (BG) involvement has been reported to be associated with clinical course. We investigated the association of clinical course of sCJD with diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as well as BG involvement at early stage.
METHODS: DWI and single voxel proton MRS were performed in 14 patients with sCJD during the initial diagnostic workup. Apparent diffusion coefficient (ADC) and metabolites were measured in medial occipitoparietal cortices where large hyperintense DWI lesions were found in all patients. The presence or absence of BG involvement, ADC, N-acetylaspartate (NAA)/creatine (Cr) ratios, and choline (Cho)/Cr ratios were correlated with disease duration (i.e., the time from the symptom onset to death).
RESULTS: The disease duration ranged from 2 to 31 months (median, 16). Hyperintense DWI lesions were observed bilaterally in both cortices and basal ganglia in eight patients and in cortices alone in six patients. Patients with BG involvement had shorter disease duration (median, 6.8 versus 20.5; p = 0.039) than those without and lower NAA/Cr ratios (median, 1.41 versus 2.03; p = 0.001). ADC and Cho/Cr ratios were not significantly different between the patients with BG involvement and those without. By multiple regression analysis, NAA/Cr ratios had the greatest correlation with the disease duration (p = 0.029).
CONCLUSION: The disease duration of sCJD was variable. NAA/Cr ratios of the affected brain at the early stage of sCJD can be used as a useful parameter in predicting the clinical course.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221559     DOI: 10.1007/s00234-010-0820-4

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  22 in total

Review 1.  Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?

Authors:  Oscar E Mendez; Jingzi Shang; Charles A Jungreis; Daniel I Kaufer
Journal:  J Neuroimaging       Date:  2003-04       Impact factor: 2.486

2.  Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt-Jakob disease.

Authors:  Philippe Demaerel; Raf Sciot; Wim Robberecht; René Dom; Dirk Vandermeulen; Frederik Maes; Guido Wilms
Journal:  J Neurol       Date:  2003-02       Impact factor: 4.849

3.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

4.  Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI.

Authors:  M Matoba; H Tonami; H Miyaji; H Yokota; I Yamamoto
Journal:  J Comput Assist Tomogr       Date:  2001 Mar-Apr       Impact factor: 1.826

5.  Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease.

Authors:  H G Pandya; S C Coley; I D Wilkinson; P D Griffiths
Journal:  Clin Radiol       Date:  2003-02       Impact factor: 2.350

6.  Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease.

Authors:  Sanjay Mittal; Peter Farmer; Peter Kalina; Peter B Kingsley; John Halperin
Journal:  Arch Neurol       Date:  2002-01

7.  Relationship between clinical course and Diffusion-weighted MRI findings in sporadic Creutzfeldt-Jakob Disease.

Authors:  Sang-Hun Yi; Key-Chung Park; Sung-Sang Yoon; Eui-Jong Kim; Won-Chul Shin
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

8.  Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings.

Authors:  B Meissner; K Körtner; M Bartl; U Jastrow; B Mollenhauer; A Schröter; M Finkenstaedt; O Windl; S Poser; H A Kretzschmar; I Zerr
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

9.  Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; A Krasnianski; U Heinemann; D Varges; M Knauth; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

10.  Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease.

Authors:  G D Graham; O A Petroff; A M Blamire; G Rajkowska; P Goldman-Rakic; J W Prichard
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

View more
  13 in total

1.  [Sporadic Creutzfeldt-Jakob disease imitates posterior reversible encephalopathy syndrome].

Authors:  Schulamith Krüger; Jörg Larsen; Jens Schaumberg
Journal:  Nervenarzt       Date:  2019-06       Impact factor: 1.214

2.  Diagnostic value of diffusion-weighted brain magnetic resonance imaging in patients with sporadic Creutzfeldt-Jakob disease: a systematic review and meta-analysis.

Authors:  Ho Young Park; Minjae Kim; Chong Hyun Suh; Sang Yeong Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-05-12       Impact factor: 5.315

3.  Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt-Jakob disease.

Authors:  Ting Gao; Jin-Hao Lyu; Jia-Tang Zhang; Xin Lou; Wei Zhao; Xiao-Wei Xing; Ming Yang; Yan Yao; Qing-Che Tan; Cheng-Lin Tian; Xu-Sheng Huang; Lin Ma; Sheng-Yuan Yu
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

4.  A study of clinical profile, radiological and electroencephalographic characteristics of suspected Creutzfeldt-Jakob disease in a tertiary care centre in South India.

Authors:  Rohan R Mahale; Mahendra Javali; Anish Mehta; Suryanarayana Sharma; Purushottam Acharya; Rangasetty Srinivasa
Journal:  J Neurosci Rural Pract       Date:  2015-01

Review 5.  Neuroradiology of human prion diseases, diagnosis and differential diagnosis.

Authors:  Simona Gaudino; Emma Gangemi; Raffaella Colantonio; Annibale Botto; Emanuela Ruberto; Rosalinda Calandrelli; Matia Martucci; Maria Gabriella Vita; Carlo Masullo; Alfonso Cerase; Cesare Colosimo
Journal:  Radiol Med       Date:  2017-01-21       Impact factor: 3.469

6.  In Vivo Longitudinal (1)H MRS Study of Transgenic Mouse Models of Prion Disease in the Hippocampus and Cerebellum at 14.1 T.

Authors:  Cristina Cudalbu; Melanie Craveiro; Vladimir Mlynárik; Juliane Bremer; Adriano Aguzzi; Rolf Gruetter
Journal:  Neurochem Res       Date:  2015-07-23       Impact factor: 3.996

Review 7.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 8.  Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015).

Authors:  Giulio Zuccoli; Michael Paul Yannes; Raffaele Nardone; Ariel Bailey; Amy Goldstein
Journal:  Neuroradiology       Date:  2015-07-31       Impact factor: 2.804

9.  Illustrating the relevance of updated diagnostic criteria for sporadic Creutzfeldt-Jakob disease: a teaching neurocase.

Authors:  Joseph Kamtchum Tatuene; Maria Isabel Vargas; Karim Burkhardt; Michel Chofflon
Journal:  BMJ Case Rep       Date:  2013-08-28

10.  Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.

Authors:  Laura Eisenmenger; Marie-Claire Porter; Christopher J Carswell; Andrew Thompson; Simon Mead; Peter Rudge; John Collinge; Sebastian Brandner; Hans R Jäger; Harpreet Hyare
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.